WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $254.78 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $254.34, a 20.54% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $211.00, a 39.75% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $350.18, a 14.18% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $306.68, a 16.92% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $219.70, a 36.91% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $348.25, a 13.45% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $306.97, a 15.78% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $364.47, a 30.07% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $254.78 10-Q · filed 2026-07-23 | ||||
| 2026-03-31 | $254.34 10-Q · filed 2026-04-23 | ||||
| 2025-12-31 | $219.70 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $218.98 10-Q · filed 2025-10-23 | ||||
| 2025-06-30 | $211.39 10-Q · filed 2025-07-24 | ||||
| 2025-03-31 | $211.00 10-Q · filed 2025-04-24 | ||||
| 2024-12-31 | $348.25 10-K · filed 2025-02-18 | ||||
| 2024-09-30 | $348.50 10-Q · filed 2024-10-24 | ||||
| 2024-06-30 | $350.28 10-Q · filed 2024-07-25 | ||||
| 2024-03-31 | $350.18 10-Q · filed 2024-04-25 | ||||
| 2023-12-31 | $306.97 10-K · filed 2024-02-20 | ||||
| 2023-09-30 | $306.92 10-Q · filed 2023-10-26 | ||||
| 2023-06-30 | $306.92 10-Q · filed 2023-07-27 | ||||
| 2023-03-31 | $306.68 10-Q · filed 2023-04-27 | ||||
| 2022-12-31 | $364.47 10-K · filed 2023-02-21 | ||||
| 2022-09-30 | $366.15 10-Q · filed 2022-10-27 | ||||
| 2022-06-30 | $366.86 10-Q · filed 2022-07-28 | ||||
| 2022-03-31 | $369.13 10-Q · filed 2022-04-28 | ||||
| 2021-12-31 | $280.22 10-K · filed 2022-02-22 | ||||
| 2021-09-30 | $277.23 10-Q · filed 2021-10-28 | ||||
| 2021-06-30 | $275.02 10-Q · filed 2021-07-30 | ||||
| 2021-03-31 | $274.29 10-Q · filed 2021-04-30 | ||||
| 2020-12-31 | $178.11 10-K · filed 2022-02-22 | ||||
| 2020-09-30 | $175.22 10-Q · filed 2020-10-23 | ||||
| 2020-06-30 | $173.68 10-Q · filed 2020-07-24 | ||||
| 2020-03-31 | $173.22 10-Q · filed 2020-04-24 | ||||
| 2019-12-31 | $103.40 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $102.59 10-Q · filed 2019-10-29 | ||||
| 2019-06-30 | $102.51 10-Q · filed 2019-07-29 | ||||
| 2019-03-31 | $102.51 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $90.36 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $90.05 10-Q · filed 2018-10-30 | ||||
| 2018-06-30 | $90.10 10-Q · filed 2018-07-31 | ||||
| 2018-03-31 | $89.56 10-Q · filed 2018-05-08 | ||||
| 2017-12-31 | $84.09 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $83.88 10-Q · filed 2017-10-31 | ||||
| 2017-06-30 | $83.92 10-Q · filed 2017-08-01 | ||||
| 2017-03-31 | $83.47 10-Q · filed 2017-05-05 | ||||
| 2016-12-31 | $61.98 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $63.75 10-Q · filed 2016-10-31 | ||||
| 2016-06-30 | $61.55 10-Q · filed 2016-08-01 | ||||
| 2016-03-31 | $59.59 10-Q · filed 2016-05-06 | ||||
| 2015-12-31 | $56.06 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $55.63 10-Q · filed 2015-11-02 | ||||
| 2015-06-30 | $55.62 10-Q · filed 2015-08-03 | ||||
| 2015-03-31 | $54.07 10-Q · filed 2015-05-06 | ||||
| 2014-12-31 | $47.59 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $47.21 10-Q · filed 2014-11-03 | ||||
| 2014-06-30 | $47.26 10-Q · filed 2014-08-01 | ||||
| 2014-03-31 | $47.33 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $29.71 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $29.71 10-Q · filed 2013-11-04 | ||||
| 2013-06-30 | $59.43 10-Q · filed 2013-08-05 | ||||
| 2013-03-31 | $59.25 10-Q · filed 2013-05-06 | ||||
| 2012-12-31 | $21.47 10-K · filed 2015-02-25 | $42.94 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $42.94 10-Q · filed 2012-11-05 | ||||
| 2012-03-31 | $42.44 10-Q · filed 2012-08-06 | ||||
| 2011-12-31 | $20.43 10-K · filed 2014-02-27 | $40.85 10-K · filed 2013-02-27 | |||
| 2010-12-31 | $42.47 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |